These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 2292201)

  • 1. Pharmacokinetics of ciprofloxacin in liver cirrhosis.
    Ruhnke M; Trautmann M; Borner K; Hopfenmüller W
    Chemotherapy; 1990; 36(6):385-91. PubMed ID: 2292201
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The pharmacokinetics of ciprofloxacin in patients with renal function of various degrees].
    Yu H; Wang HY; Sun ZM
    Zhonghua Nei Ke Za Zhi; 1994 Jul; 33(7):449-51. PubMed ID: 7867438
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elimination of ciprofloxacin and three major metabolites and consequences of reduced renal function.
    Bergan T; Thorsteinsson SB; Rohwedder R; Scholl H
    Chemotherapy; 1989; 35(6):393-405. PubMed ID: 2612228
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of cirrhosis on the steady-state pharmacokinetics of oral ciprofloxacin.
    Frost RW; Lettieri JT; Krol G; Shamblen EC; Lasseter KC
    Clin Pharmacol Ther; 1989 Jun; 45(6):608-16. PubMed ID: 2731404
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of ciprofloxacin in patients with liver cirrhosis.
    Dixit RK; Satapathy SK; Kumar R; Dhiman RK; Garg SK; Taneja S; Bhargava VK; Chawla YK
    Indian J Gastroenterol; 2002; 21(2):62-3. PubMed ID: 11990328
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of ciprofloxacin in patients with acute renal failure undergoing continuous venovenous haemofiltration: influence of concomitant liver cirrhosis.
    Bellmann R; Egger P; Gritsch W; Bellmann-Weiler R; Joannidis M; Dunzendorfer S; Wiedermann ChJ
    Acta Med Austriaca; 2002; 29(3):112-6. PubMed ID: 12168566
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of ciprofloxacin in the elderly.
    Bayer A; Gajewska A; Stephens M; Stark JM; Pathy J
    Respiration; 1987; 51(4):292-5. PubMed ID: 3659579
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of ciprofloxacin in impaired liver function.
    Esposito S; Miniero M; Barba D; Sagnelli E
    Int J Clin Pharmacol Res; 1989; 9(1):37-41. PubMed ID: 2707924
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of fluoroquinolones in hepatic failure.
    Montay G; Gaillot J
    J Antimicrob Chemother; 1990 Oct; 26 Suppl B():61-7. PubMed ID: 2258353
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transintestinal elimination of ciprofloxacin.
    Rohwedder R; Bergan T; Thorsteinsson SB; Scholl H
    Chemotherapy; 1990; 36(2):77-84. PubMed ID: 2311444
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Population pharmacokinetics of ciprofloxacin in patients with liver impairments analyzed by NPEM2 algorithm--a retrospective study.
    Terziivanov D; Atanasova I; Dimitrova V
    Int J Clin Pharmacol Ther; 1998 Jul; 36(7):376-82. PubMed ID: 9707352
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics of ciprofloxacin in the elderly: increased oral bioavailability and reduced renal clearance.
    Ljungberg B; Nilsson-Ehle I
    Eur J Clin Microbiol Infect Dis; 1989 Jun; 8(6):515-20. PubMed ID: 2504591
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of ciprofloxacin XR (1000 mg) versus levofloxacin (500 mg) in plasma and urine of male and female healthy volunteers receiving a single oral dose.
    Wagenlehner FM; Kinzig-Schippers M; Tischmeyer U; Wagenlehner C; Sörgel F; Dalhoff A; Naber KG
    Int J Antimicrob Agents; 2006 Jan; 27(1):7-14. PubMed ID: 16343856
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics, renal clearance and metabolism of ciprofloxacin following intravenous and oral administration to calves and pigs.
    Nouws JF; Mevius DJ; Vree TB; Baars AM; Laurensen J
    Vet Q; 1988 Jul; 10(3):156-63. PubMed ID: 3176294
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of oral ciprofloxacin in healthy, young Brazilian subjects.
    Sudo RT; Melo PA; Suarez-Kurtz G
    Braz J Med Biol Res; 1990; 23(12):1315-21. PubMed ID: 2136565
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Urinary bactericidal activity, urinary excretion and plasma concentrations of gatifloxacin (400 mg) versus ciprofloxacin (500 mg) in healthy volunteers after a single oral dose.
    Boy D; Well M; Kinzig-Schippers M; Sörgel F; Ankel-Fuchs D; Naber KG
    Int J Antimicrob Agents; 2004 Mar; 23 Suppl 1():S6-16. PubMed ID: 15037323
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Single and multiple dose pharmacokinetics of oral ciprofloxacin in elderly patients.
    Guay DR; Awni WM; Peterson PK; Obaid S; Stein D; Breitenbucher R; Matzke GR
    Int J Clin Pharmacol Ther Toxicol; 1988 Jun; 26(6):279-84. PubMed ID: 3410603
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An overview of the pharmacology of intravenously administered ciprofloxacin.
    Drusano GL
    Am J Med; 1987 Apr; 82(4A):339-45. PubMed ID: 3578325
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics of intravenously administered ciprofloxacin in patients with various degrees of renal function.
    Drusano GL; Weir M; Forrest A; Plaisance K; Emm T; Standiford HC
    Antimicrob Agents Chemother; 1987 Jun; 31(6):860-4. PubMed ID: 3619418
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Steady-state serum pharmacokinetics and bioequivalence of 500 mg oral versus 200 mg intravenous ciprofloxacin.
    Garraffo R; Dellamonica P; Bernard E; Etesse H; Lapalus P
    Int J Clin Pharmacol Res; 1989; 9(1):29-35. PubMed ID: 2707923
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.